Workflow
节余募集资金使用
icon
Search documents
艾为电子: 中信证券股份有限公司关于上海艾为电子技术股份有限公司部分募投项目结项并将节余募集资金用于其他募投项目及部分募投项目延期的核查意见
Zheng Quan Zhi Xing· 2025-08-13 12:19
Summary of Key Points Core Viewpoint The company has completed certain fundraising projects and plans to allocate surplus funds to other investment projects while also postponing some projects based on practical considerations and market demands [2][6][9]. Fundraising Overview - The company raised a total of RMB 3,201,044,000 by issuing 41.8 million shares at a price of RMB 76.58 per share, with a net amount of RMB 3,035,261,414.64 after deducting issuance costs [2][3]. - The total investment amount for the initial projects was RMB 246,813.72 million, all funded by the raised capital [3]. Investment Project Updates - The company has decided to use the remaining surplus funds of RMB 47,220 million for new projects, with a total planned investment of RMB 47,747.45 million [3][5]. - The investment in the "Electronic Engineering Testing Center Construction Project" has been adjusted, increasing its total investment from RMB 73,858.20 million to RMB 94,041.80 million [3][4]. Surplus Fund Utilization - The surplus funds from completed projects amount to RMB 21,043.78 million, with plans to allocate RMB 20,075.57 million to the "High-Performance Analog Chip R&D and Industrialization Project" [5][6]. - The company emphasizes efficient use of funds and has implemented strict cost control measures during project execution [4][5]. Project Postponement - The timeline for the "High-Performance Analog Chip R&D and Industrialization Project" has been extended to December 2027 due to the need for further market analysis and product optimization [7][8]. - The postponement is deemed necessary to ensure the project aligns with market demands and does not adversely affect the company's operations [8]. Approval Process - The decisions regarding project completion, fund allocation, and postponement have been reviewed and approved by the company's board and supervisory committee, ensuring compliance with regulatory requirements [9][10].